Clinical applications of granulocyte colony-stimulating factor: an update and summary
✍ Scribed by K. Hübel; A. Engert
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 158 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The multilineage hematopoietic effects of IL-3 appear to be most important for its clinical use comprising especially leucocyte and platelet responses. This was demonstrated to be dose dependent characterising doses of 250 to 500 micrograms/m2/day subcutaneously as hematopoietic effective and well t
Expression of a maize storage protein gene in petunia plants is not restricted to seeds.
## Abstract We previously established 2 lung cancer cell lines, OKa‐C‐1 and MI‐4, which constitutively produce an abundant dose of granulocyte‐colony stimulating factor (G‐CSF) and granulocyte macrophage‐colony stimulating factor (GM‐CSF). Many other cases with G‐CSF or GM‐CSF producing tumors have